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ABSTRACT: Gene knockdown has emerged as an important tool for cancer gene therapy as well as for viral infections and
dominantly inherited genetic disorders. The generation of suitable siRNA delivery systems poses some challenges, namely, to
avoid nuclease degradation, to surpass the cytoplasmic membrane, and to release the nucleic acids into the cytosol. Aiming at
evaluating the ability of thermoresponsive block copolymers formed by units of N-isopropylacrylamide and of (3-
acrylamidopropyl)trimethylammonium chloride to efficiently deliver siRNAs, an extensive study was performed with four
different copolymers using a human fibrosarcoma cell line as cell model. The silencing ability and cytotoxicity of the generated
copolymer-based siRNA delivery systems were found to be dependent on the cloud point of the polymer, which corresponds to
the transition temperature at which the aggregation or precipitation of the polymer molecules becomes thermodynamically more
favorable than their solubilization. In the present study, a system capable of delivering siRNAs efficiently, specifically and without
presenting relevant cytotoxicity, even in the presence of serum, was developed. Confocal fluorescence experiments showed that
the ability of the generated systems to silence the target gene is related to some extent to nucleic acid internalization, being also
dependent on polymer/siRNA dissociation at 37 °C. Thus, a delicate balance between nucleic acid internalization and
intracellular release must be met in order to reach an ideal knockdown efficiency. The special features and potential for
manipulation of the N-isopropylacrylamide-based copolymers make them suitable materials for the design and synthesis of new
and promising siRNA delivery systems.
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■ INTRODUCTION
RNA interference (RNAi) is a powerful gene silencing process
that holds a great therapeutic potential in several diseases, such
as cancer.1 Small interfering RNAs (siRNAs), first described in
2001 as promoting effective RNA interference in mammalian
cells without inducing interferon immunological response,2 are
short double stranded RNA (dsRNA) molecules (less than 30
nucleotides in length) that mediate post-transcriptional
silencing of target genes through degradation of their
mRNAs.3 This process is highly efficient and sequence-
dependent, thus conferring specificity to the silencing
mechanism. In Nature, siRNAs are produced as an antiviral
defense, silencing mobile genetic elements resulting from viral
infections. For therapeutic purposes, siRNAs have been
delivered into cells using adequate carrier systems able to
overcome membrane barriers and to release the nucleic acids
into the cytosol, in order to allow their loading into the RNA-
induced silencing complex (RISC) and the consequent specific
mRNA knockdown.3 Several different nonviral delivery
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systems, including cationic lipids, peptides, and polymers, have
been developed to introduce siRNAs into the cell cytoplasm,
where they are active.4−7
Some polymeric units, such as N-isopropylacrylamide
(NIPAAM), are thermoresponsive and display a nonlinear
relationship between solubility and temperature, exhibiting a
sharp thermotropic transition between a soluble and an
insoluble state.8 The phase transition temperature, known as
cloud point or lower critical solution temperature (LCST),
represents a transition from a hydrated form (due to the
formation of water−polymer hydrogen bonds) to a non-
hydrated form of the polymers, in which the disruption of the
hydrogen bonds is entropically favored, leading to collapse or
macroscopic phase separation of the polymers depending on
the polymer concentration.9 Since the cloud point of NIPAAM
was known, in 1992,8 homopolymers formed by NIPAAM units
or copolymers designed to exhibit different combinations and
ratios between NIPAAM and other different units, have been
extensively studied for biomedical applications, including
controlled delivery of therapeutic molecules and tissue
engineering.10 One of the reasons why the polymers containing
NIPAAM have gained increasing interest in therapeutic
applications resides on the possibility of modulating their
thermoresponsiveness by varying several parameters, such as
salt concentration, pH, and composition or relative abundance
of polymer components.11,12
A polymer composed of several NIPAAM units, that is a
poly-NIPAAM (PNIPAAM), hydrophobically aggregates at
temperatures above 32 °C, depending on concentration and
molecular weight,12 and this proximity to human body
temperature makes it particularly interesting for pharmaceutical
and biomedical applications.13 Importantly, by copolymeriza-
tion with other hydrophilic or hydrophobic blocks, one can
increase or decrease the phase transition temperature of the
polymer, for specific applications.14 For instance, copolymeriza-
tion with hydrophilic blocks to produce polymers with a cloud
point close to 37 °C has revealed to be particularly
advantageous since these molecules are sensitive to the
physiological temperature, thus changing their structure when
incorporated in the human organism. Therefore, complexes of
these copolymers with nucleic acids, formed at temperatures
below the polymer cloud point, are expected to display the
ability to release the complexed molecule into human cells or
body fluids due to a collapse of the polymeric structure at the
physiological temperature.10 In this context, the addition of a
cationic unit, such as (3-acrylamidopropyl)trimethylammonium
chloride (AMPTMA), to the NIPAAM structure was envisaged
to accomplish two purposes: to increase the cloud point of the
polymer10,12 and to confer positive charges to the overall
molecule.15 The addition of cationic units to hydrophobic
polymers has been reported as making the polymer more prone
to efficiently complex negatively charged biomolecules such as
nucleic acids and to interact with negatively charged cell
membranes.15 This approach has been applied to design new
copolymer-based plasmid DNA delivery systems, creating
molecular combinations with delivery competence that none
of the individual components of the copolymer exhibit due to
cytotoxicity or impairment of specific steps in the delivery
process, such as cellular internalization and endosomal escape.
The main objective of combining two distinct monomers in the
copolymer is to ally advantageous properties of each one and to
minimize their deficiencies in order to accomplish an effective
delivery.16
In this work, four diblock copolymers were synthesized as
p o l y (N - i s o p r o p y l a c r y l a m i d e ) n - b l o c k - p o l y ( ( 3 -
acrylamidopropyl)trimethylammonium chloride)m, abbreviated
herein as PNIPAAMn-b-PAMPTMA(+)m, or n:m (n = 48 or 65
and m = 6, 10, or 20), which exhibit different cloud points and
molecular weights. These block copolymers, which have already
shown to be promising candidates as DNA nonviral carriers,17
were used in the present work to investigate their ability to
efficiently deliver siRNA to HT1080 cells (a human
fibrosarcoma cell line) in the absence and presence of serum.
To the best of our knowledge, only one study has addressed the
generation of a PNIPAAM-containing system for siRNA
delivery,18 which was composed of quantum dots cografted
with a cell penetrating peptide. Our results show that nucleic
acid protection conferred by the polymers, associated with their
ability to mediate cell internalization of the siRNAs and the
polymer/siRNA dissociation, is responsible for silencing a
target protein.
These data shed light on the great variety of existing
possibilities to design new and more efficient siRNA delivery
systems, with the ultimate goal of developing a useful tool to
modulate gene expression with implications in several fields,
such as functional genomics, drug validation, and even
transgenic design.19−22
■ EXPERIMENTAL SECTION
Materials. The anti-GFP siRNA (5′-GCAAGCUGACC-
CUGAAGUUCAU-3′) and Cy3-labeled nonspecific siRNA
sequence were purchased from Ambion (Austin, TX, USA).
The nonsilencing siRNA sequence used as control was
obtained from Dharmacon (Lafayette, CO, USA). All the
other chemicals were of the highest grade.
Charged Block Copolymers. The cationic diblock
copolymers poly(N-isopropylacrylamide)n-block-poly((3-
acrylamidopropyl)trimethylammonium chloride)m (PNI-
PAAMn-b-PAMPTMA(+)m) with n = 48 or 65 and m = 6,
10, or 20 (Figure 1) were synthesized via a simple one-pot
atom transfer radical polymerization (ATRP) procedure, as
previously reported.23,24 The chemical structure of the diblock
copolymers used in this study is illustrated in Figure 1, and
their cloud point values and molecular weights are presented in
Table 1.
Cells. HT1080 cells (a human fibrosarcoma cell line that was
stably transfected to express GFP endogenously) were
maintained at 37 °C, under 5% CO2, in Dulbecco Modified
Eagle low glucose (DMEM-LG; Sigma) supplemented with
10% (v/v) heat-inactivated fetal bovine serum (FBS; Biochrom
Figure 1. Schematic representation of the chemical structure of the
PNIPAAMn-b-PAMPTMA(+)m diblock copolymers (n = 48 or 65 and
m = 6, 10, or 20).
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KG), and with 100 units of penicillin and 100 μg of
streptomycin (Sigma) per mL.
Preparation of Polymer/siRNA Complexes. Polymers
were dissolved in cell culture medium (OptiMEM or DMEM-
LG) and gently mixed with siRNA targeting GFP (50 nM/
well), at the desired polymer/siRNA (+/−) charge ratios. The
mixtures were further incubated for 20 min at room
temperature. Polymer/siRNA complexes were used immedi-
ately after being prepared.
Determination of the Hydrodynamic Diameter of
Polymer/siRNA Complexes. Polyplexes were characterized
with respect to their hydrodynamic diameter in HBS buffer, at
25 and 37 °C, by photon correlation spectroscopy-based
technique (PCS) using a Coulter N4 Plus (Coulter
Corporation, Miami, FL, USA). PCS uses photon correlation
spectroscopy of scattered laser light to determine its time-
dependent fluctuations resulting from the Brownian motion of
particles in suspension. The light intensity scattered at a given
angle is detected by a detector (at fixed angle of 90°) whose
output current is passed to a photocorrelator, which analyses
time dependence, determining the rate of diffusion or Brownian
motion of the particles and hence their hydrodynamic
diameter.25 Complexes were prepared immediately before
analysis. All complexes showed a monomodal hydrodynamic
diameter distribution.
Evaluation of Cell Viability. Cell viability was assessed
under the different experimental conditions by a modified
Alamar blue assay, as described previously.26 Briefly, 48 h post-
transfection, the cells were incubated with DMEM-LG (10%
serum) containing 10% (v/v) resazurin dye. After 1 h
incubation at 37 °C, the absorbance of the medium was
measured at 570 and 600 nm (supplier indication). Cell
viability was calculated as a percentage of the nontransfected
control cells, according to eq 1:
= − ′ − ′ ×A A A A
cell viability (% of control)
[( )/( )] 100570 600 570 600 (1)
where A570 and A600 are the absorbances of the samples, and
A′570 and A′600 are those of the control (nontreated cells), at
the indicated wavelengths.
Analysis of GFP Silencing. HT1080 cells (1.0 × 105 cells/
well) were seeded in 12-well plates. Following overnight
culture, the cells were incubated with the different complexes
(50 nM of siRNA per well) at 37 °C for 4 h, in OptiMEM (no
serum) or DMEM-LG (10% serum) media. After this period,
the medium was replaced with fresh complete medium
containing 10% (v/v) FBS and antibiotics, and the cells were
further incubated for 44 h to allow gene expression. Parallel
experiments were performed with a control siRNA (nontarget
siRNA or siRNA mut). The knockdown efficiency mediated by
the different complexes was evaluated by analyzing GFP
silencing by flow cytometry. Briefly, 48 h after transfection, the
cells were washed once with PBS and detached with trypsin (10
min at 37 °C). The cells were further washed three times by
centrifugation (5 min, 1000 rpm) in ice-cold PBS and
immediately analyzed, using a Becton Dickinson FACSCalibur
flow cytometer (BD Biosciences, San Jose, CA, USA). Data
obtained were analyzed using CellQuest software. To
discriminate between viable and dead cells and to exclude
doublets, cells were appropriately gated by forward/side scatter
and pulse width from a total of 10 000 events. The FITC
bandpass filter was used in emission detection. GFP silencing
was expressed as geometric mean fluorescence intensity with
respect to control (nontreated) cells.
Analysis of siRNA Internalization and Intracellular
Distribution. HT1080 cells (0.2 × 105 cells/well) were plated
in 8-well chambered coverslips (Lab-Tek II Chamber Slide
System Nunc). Following overnight culture, the cells were
incubated, for 4 h, with the different polymer/siRNA delivery
systems formulated with noncoding Cy3-labeled siRNAs (50
nM), in OptiMEM medium. After this period, cells were
washed twice with PBS and incubated with Hoechst 33342 dye
(1 μg/mL, Molecular Probes, Eugene, OR). Cells were then
washed twice with PBS and directly observed in the chambers
in 0.5 mL of PBS. Fluorescence distribution inside cells was
analyzed under a Zeiss Axiovert 200 M confocal microscope
(Carl Zeiss, Oberk) without fixation, using the 60× oil
immersion objective.
Analysis of siRNA Protection. Complexes containing 14
pmol of siRNA prepared in a total volume of 100 μL of HBS
were allowed to incubate for 20 min at room temperature and
then transferred to a 96-well (blackwalled) plate (Corning, NY,
USA). A total of 100 μL of PicoGreen dye (Molecular Probes,
Eugene, OR), upon 1:200 dilution in HBS buffer (according to
the manufacturer’s instructions), was added to each well. The
fluorescence of PicoGreen, directly proportional to the amount
of accessible/free siRNA, was monitored in a Spex Fluorolog
Spectrometer at 25 and 37 °C. The excitation and emission
wavelengths were set at 485 and 520 nm, respectively. The
amount of siRNA protected by the cationic polymers was
calculated as a percentage of a control containing only a
PicoGreen solution, according to eq 2:
= − − −P F F F F1 [( )/( )]siRNA 100 0 100 (2)
where F is the fluorescence measured after adding the
complexes to the PicoGreen solution, F0 is the maximum
fluorescence of a positive control, which accounts for 0% of
siRNA protection, and F100 is the minimum fluorescence of a
negative control taken as 100% of protection. For the positive
control, free siRNA, in the same amount as that associated with
the complexes, was used and a PicoGreen solution without
siRNA was used as the negative control.
Statistical Analysis. Data are presented as mean ± SD.
The significance of the results was statistically analyzed by a
one-way analysis of variance (ANOVA) with Tukey’s multiple
pairwise comparison, unless stated otherwise. Statistical
significance was set at p < 0.05.
Table 1. Cloud Points and Molecular Weights of the PNIPAAMn-b-PAMPTMA(+)m Block Copolymers
polymer
PNIPAAM48-b-PAMPTMA(+)6
(48:6)
PNIPAAM48-b-PAMPTMA(+)10
(48:10)
PNIPAAM48-b-PAMPTMA(+)20
(48:20)
PNIPAAM65-b-PAMPTMA(+)20
(65:20)
cloud point
(°C)a
35 36 37 34
Mw (g/mol)
a 6770 7600 9690 11600
aCloud point and molecular weight data were taken from ref 17.
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■ RESULTS
Hydrodynamic Diameter of the Polymer/siRNA Com-
plexes. Because of the temperature-dependent structural
properties displayed by the polymers used in this study, the
average diameter of their complexes with siRNA was evaluated
at 25 and 37 °C. As shown in Table 2, polyplexes prepared
from n:m 48:20 exhibited the largest hydrodynamic diameters
at 25 °C (820 and 583 nm, when prepared at 2/1 and 10/1
(+/−) charge ratios, respectively). For the same length of
polymer thermoresponsive moiety (n = 48), the increase in the
number of cationic units (from 6 to 20) led to a progressive
increase of polyplex hydrodynamic diameter. However, the
length of the thermoresponsive component also influenced
polyplex dimensions. Thus, for the same number of cationic
units (m = 20), the increase of the thermoresponsive moiety
length (from 48 to 65) promoted a decrease of polyplex
hydrodynamic diameter.
Complexes exhibited at 37 °C the same diameter as that
observed at 25 °C, except for those generated from the n:m
48:20 polymer, which showed a significant reduction in
hydrodynamic diameter with increasing temperature (to 263
and 140 nm when prepared at 2/1 and 10/1 (+/−) charge
ratios, respectively).
Cytotoxicity and Silencing Efficiency. The cytotoxicity
and silencing efficiency of complexes (polyplexes) composed of
siRNA targeting GFP and each of four PNIPAAMn-b-
PAMPTMA(+)m block copolymers with different cloud points
were evaluated in HT1080 cells, both in the absence and
presence of 10% serum.
In the absence of serum, the toxicity exerted by the
polyplexes showed high dependence on the polymer/siRNA
(+/−) charge ratio (Figure 2A). At the lowest (+/−) charge
ratio tested (2/1), only the n:m 65:20 polymer-containing
complexes exhibited some toxicity, inducing a decrease of 37%
in cell viability. At the polymer/siRNA (+/−) charge ratios of
5/1 and 10/1, the complexes were toxic, causing a reduction of
cell viability to values between 60% [n:m 48:20 at 10/1 (+/−)
charge ratio] and 30% [n:m 65:20 at 10/1 (+/−) charge ratio],
except for the n:m 48:20 polymer-containing complexes at the
5/1 (+/−) charge ratio, which decreased the cell viability only
to 84%. The n:m 48:20-based complexes were, therefore, the
least toxic to the cells in the absence of serum. Comparatively,
the cytotoxicity of the complexes in the presence of serum was
in general less severe (Figure 2B). In this case, only for the
highest (+/−) charge ratio tested (10/1), the complexes
showed significant cytotoxicity. The most pronounced toxic
effect was observed for the complexes containing the n:m 65:20
polymer, the cell viability reaching values of 46% and 32% in
the presence of complexes at 5/1 and 10/1 (+/−) charge
ratios, respectively.
Regarding the silencing efficiency for cells incubated with the
complexes in the absence of serum (Figure 2C), only the
formulations that exhibited cytotoxicity displayed unspecific
silencing. As observed, complexes prepared at the lowest (+/−)
charge ratios (particularly at the 2/1 charge ratio), at which
they exhibited low or no toxic effects, showed high ability to
specifically silence the target gene (black columns). Remark-
ably, the n:m 48:6 polymer/siRNA complexes, prepared at the
2/1 (+/−) charge ratio, were able to suppress gene expression
in 36% in a specific manner. In the presence of serum, the
silencing specificity of the complexes decreased, as deduced
from the knockdown effect observed when the complexes were
formulated with the nontarget siRNA (white bars in Figure
2D). Despite this being the general scenario, it is important to
note that complexes of the n:m 48:20 polymer and siRNA, at
the 10/1 (+/−) charge ratio, presented a significantly lower
unspecific silencing effect in the presence of serum than in its
absence. In this case, for complexes formulated with the
nontarget siRNA, GFP expression was reduced to 55% of the
control in the absence of serum and to 67% in the presence of
serum. However, as shown in Figure 2C,D, upon knockdown
with the siRNA targeting GFP, protein expression was 34% and
32% of the control, in the presence and absence of serum,
respectively, thus revealing an improvement of the performance
of these complexes under conditions mimicking more closely
those in vivo, regarding their specific effect on the target gene.
siRNA Internalization and Intracellular Distribution.
Aiming at comparing the extent of cellular internalization and
distribution of siRNA molecules mediated by polyplexes
displaying different levels of specific silencing, complexes
containing the polymers n:m 48:6 and 48:20 at polymer/
siRNA (+/−) charge ratios of 2/1 and 10/1 were selected for
confocal microscopy analysis. Figure 3 displays the siRNA
internalization patterns obtained in HT1080 cells, in the
absence of serum, for the different conditions tested. Both
untreated cells (data not shown) and cells treated with naked
siRNA (Figure 3A) were used as negative controls. In these two
cases, no siRNA red fluorescence was noticeable, which is in
accordance with the inability of the siRNA per se to enter the
cells. Lipofectamine siRNAmax was used as a positive control
(Figure 3B). As observed, this commercially available reagent
was able to deliver siRNA to cells, which displayed some
punctuated red fluorescence (round and intense red dots),
most likely reflecting siRNA entrapment inside vesicles.
However, some degree of siRNA dispersion throughout the
cells could also be deduced from the observed diffuse red
fluorescence. The n:m 48:20 copolymer showed a poor ability
to mediate the entry of siRNA into the cells after 4 h of cell
incubation with the polyplexes, both at the 2/1 and 10/1
(+/−) charge ratios (Figure 3C,D). However, the pattern of
distribution of siRNAs delivered by the 10/1 (+/−) charge
ratio complexes was more diffuse than that of siRNAs delivered
by lipofectamine siRNAmax, indicating that siRNA internal-
ization mediated by the polymer-based complexes was followed
by its release from intracellular vesicles into the cytosol.
However, complexes containing the n:m 48:6 copolymer were
able to overload the cells with siRNA, at both charge ratios
Table 2. Mean Hydrodynamic Diameter of the Polymer/
siRNA Complexes Obtained at 25 and 37 °C
hydrodynamic diameter (nm)a
n:m (+/−) charge ratio 25 °C 37 °C
48:6 2/1 179 ± 34 134 ± 63
10/1 280 ± 7 309 ± 78
48:10 2/1 306 ± 68 217 ± 38
10/1 336 ± 12 427 ± 16
48:20 2/1 820 ± 82 264 ± 51***
10/1 583 ± 23 140 ± 61***
65:20 2/1 299 ± 25 295 ± 68
10/1 442 ± 67 420 ± 52
aResults represent the mean ± SD from three independent
experiments. Data comparisons were performed between the hydro-
dynamic diameters of complex formulations measured at 25 and 37 °C
(***p < 0.001).
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tested, as deduced from the intense and widely distributed red
fluorescence observed throughout the cytoplasm (Figure 3E,F),
thus showing their efficacy to promote both siRNA cellular
uptake and cytoplasmic delivery.
siRNA Protection Conferred by the Polymers. The
ability of the generated copolymers to confer protection to the
siRNA was assessed by Picogreen fluorescence at 25 and 37 °C
(Figure 4). This assay takes advantage of the probe
fluorescence emission only occurring upon probe intercalation
in the nucleic acid structure. Therefore, the fluorescence
measured in this assay reflects the accessibility of the nucleic
acid in solution.
As observed, all the polymers studied herein were able to
efficiently shield the siRNA molecules at 25 °C, with protection
levels between 70 and 87%, over the range of the tested charge
ratios. However, results obtained from parallel experiments
performed at 37 °C showed that the copolymers essentially lost
the capacity to protect the carried siRNAs. As observed, the
maximum protection (30%) was attained for complexes
produced from the n:m 48:6 block copolymer and siRNA at
the (+/−) charge ratio of 2/1. Surprisingly, at this temperature
(37 °C), the polymers showed a tendency for decreased ability
to protect the siRNA molecules with increasing (+/−) charge
ratio. In fact, it should be expected that increasing the relative
amount of the cationic molecule would increase the wrapping
of the siRNAs, leading to a more efficient shielding of the
carried nucleic acid molecules. That behavior was particularly
noticed for polyplexes prepared from the copolymer n:m 48:20,
while for the polyplexes based on n:m 48:6, 48:10, and 65:20
copolymers the degree of protection did not vary significantly
with the (+/−) charge ratio.
■ DISCUSSION
The temperature dependence of the structural properties
exhibited by PNIPAAM-based block copolymers has been
extensively exploited in recent years, with the purpose of
producing delivery systems with controlled release ability for
pDNA and other therapeutic molecules.10
Figure 2. Cell viability (A,B) and GFP expression (C,D) promoted by polyplexes of PNIPAAM-b-PAMPTMA and siRNA in the absence (A,C) and
in the presence of 10% serum (B,D) performed at 37 °C. Parallel experiments of GFP expression were performed with siRNA targeting GFP (■)
and a nontarget siRNA (□). The cell viability results are presented as a percentage of the control (nontreated cells, more than 98% of which are
viable), taken as 100%. Results of GFP expression are presented with respect to GFP expression of a control (nontreated cells, 80% of which express
GFP), taken as 1.0. The results represent the mean ± SD obtained from triplicates of three independent experiments. The following pairwise
comparisons were performed: cell viability or GFP expression observed in cells treated with each complex formulation were compared to the same
parameters obtained in nontreated control cells (*p < 0.01, **p < 0.005, and ***p < 0.0001; Dunnett’s multiple comparison test); each complex
formulation was compared to the same complex formulation at the immediately precedent (+/−) charge ratio (#p < 0.01, ##p < 0.005, and ###p <
0.0001); GFP expression obtained with complexes containing siRNA targeting GFP was compared with that obtained with complexes containing the
nontarget siRNA (§p < 0.01, §§p < 0.005, and §§§p < 0.0001; ns, nonsignificant).
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In this study, four cationic diblock copolymers differing in
terms of the length of the thermoresponsive and the charged
blocks were used. In a previous work,12,17 it was shown that the
length and ratio between these blocks are determinant of the
structural changes taking place as the temperature is increased,
influencing the transfection efficiency. For a constant length of
the PNIPAAM block, increasing length of the PAMPTMA(+)
block led to an increase in the hydrodynamic radius of the
polyplexes at 25 °C (48:6 < 48:10 < 48:20; Table 2). This
trend may be explained by the molecular weight increase and
also by an enhancement of the repulsive electrostatic
interactions leading to the complex expansion. However, the
smaller hydrodynamic diameter of complexes formed with the
highest molecular weight copolymer (65:20) as compared to
the complexes formed with 48:20 suggests that the temper-
ature-responsive block also plays a role in that physical
parameter. Furthermore, the fact that this temperature-
responsive contraction is observed at 25 °C suggests that the
complexation of the polymer with the nucleic acids can shift the
Figure 3. siRNA internalization mediated by different polymer-based systems at 37 °C. HT1080 cells (green) were incubated with the different
complexes containing 50 nM nontarget Cy3-labeled siRNA (red). Cell nuclei were labeled with Hoechst 33342 dye (blue). Representative confocal
microscopy images of each experimental condition (630×), taken after 4 h of cell incubation with the complexes are presented (A−F).
Representative results of siRNA internalization in cells treated with lipofectamine siRNAmax/Cy3-siRNA (B), 48:20 polymer/Cy3-siRNA (C,D),
and 48:6 polymer/Cy3-siRNA (E,F) complexes, at the indicated charge ratios, are presented. Results for cells treated with Cy3-siRNA only (siRNA
naked) are shown as a control (A).
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transition temperature of PNIPAAM to lower temperatures, in
agreement with the charge neutralization of the copolymer.
The increase of temperature from 25 to 37 °C apparently did
not promote statistically significant differences in the hydro-
dynamic radii for the polyplexes prepared with 48:6, 48:10, and
65:20 copolymers. However, the cloud point values and the
thermoresponsive behavior of the copolymers suggest that
structural changes take place as the temperature is increased.
Interplay between temperature-induced contraction of the
polyplexes (contributing to hydrodynamic diameter decrease)
and an increased aggregation number (higher number of
associating chains, contributing to hydrodynamic diameter
increase) may explain the apparently unchanged hydrodynamic
diameter of the polyplexes as the temperature is raised.
Furthermore, with the exception of polyplexes based on 48:20
copolymers, the hydrodynamic diameter of the polyplexes
increased with the increase of (+/−) charge ratio, reflecting an
increase of the aggregation number, caused by a higher number
of polymer molecules in solution. Interestingly, at 37 °C the
hydrodynamic diameter of the polyplexes prepared with 48:20
copolymers was found to be reduced as the charge ratio
increased. This suggests a significant degree of electrostatic
repulsion between the complexes formed with the long
PAMPTMA(+) block. In the 65:20-containing complexes the
electrostatic repulsions are minimized by an extremely long
PNIPAAM block.
In a therapeutic context, a siRNA delivery system must be
able to carry the nucleic acid molecules to target cells,
preventing their degradation by extracellular nucleases, and
promote their cellular internalization and release into the
cytosol. Because of the inhibitory effect exerted by serum on
transfection mediated by nonviral systems, nucleic acid delivery
is usually performed in the absence of serum. However, the
presence of serum proteins is unavoidable under in vivo
conditions. Therefore, in the present work, aiming at predicting
the in vivo behavior of the generated PNIPAAMn-b-
PAMPTMA(+)m-based polyplexes toward their successful
clinical application, the knockdown efficiency was evaluated
in the presence of serum.
The presence of serum during cell incubation with the
complexes caused a mild decrease in their biological activity, as
compared to that observed in the absence of serum. This may
reflect an unspecific interaction between the cationic moiety of
the PNIPAAM-b-PAMPTMA(+) copolymers and the neg-
atively charged serum proteins, thus preventing some
complexes to reach the cells, and thereby decreasing the
knockdown levels. Moreover, the silencing efficiency achieved
in the presence of serum was less specific than in its absence,
Figure 4. Effect of composition and (+/−) charge ratio of PNIPAAM-b-PAMPTMA-based polyplexes on siRNA protection, as assessed by
measurement of the PicoGreen fluorescence at 25 °C (gray) and at 37 °C (black). Polyplexes, prepared by incubating the copolymers n:m 48:6 (A),
48:10 (B), 48:20 (C), and 65:20 (D) with 14 pmol of siRNA, were added to a PicoGreen solution, as described in the experimental section. The
results represent the mean ± SD obtained from triplicates of three independent experiments. The degree of protection conferred by each polyplex
formulation to siRNA at 37 °C was compared to that conferred by the same formulation at 25 °C (***p < 0.001) and to that conferred by the same
formulation at the immediately precedent polymer/siRNA (+/−) charge ratio (#p < 0.05 and ###p < 0.001).
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indicating the occurrence of off-target effects. The unspecific
silencing should be avoided as it can lead to gene mutations and
cell transformation, with severe consequences, such as impair-
ment of the cellular machinery responsible for the production
of important cell survival proteins.27,28
The cloud point of the polymers (Table 1) showed to
influence both cytotoxicity and silencing efficiency. In this
regard, at the highest polymer/siRNA charge ratios tested, the
cytotoxicity induced by the complexes was inversely correlated
with the cloud point of the polymers. Both in the absence and
presence of 10% serum, the polymer with the lowest cloud
point (n:m 65:20) originated complexes that were highly toxic
to the cells. Similar observations have been made when this
polymer was used as a carrier for plasmid DNA, and this was
then associated with the formation of a compact structure
decorated with a highly charged corona.17 However, the
knockdown efficiency of the polyplexes at the 10/1 (+/−)
charge ratio in the absence of serum was found to be also
inversely correlated with the polymer transition temperature.
Indeed, the silencing activity was most effective for complexes
formed by the polymer with the lowest cloud point, with a
progressive increase in silencing efficiency according to the
following order: 48:20 < 48:10 < 48:6 < 65:20 (Figure 3). This
can be explained by the effect of the siRNAs on the cloud point
of the copolymers. Because of their negative charges, siRNA
molecules may change the ionic strength of the environment or
neutralize the charges of the cationic units of the copolymer
(which are responsible for increasing the LCST), thus altering
the thermal behavior of the complexes,10 and eventually
promoting their dissociation, by contraction of the polymer
in a coil-to-globule transition.29
Most cationic systems used to deliver nucleic acids to cells
present a protection pattern to siRNA that is consistent with
the amount of the cationic moiety employed to formulate the
complexes, increasing from the lowest to the highest charge
ratios.30,31 However, the thermoresponsive copolymers studied
herein did not present such behavior. Apparently, the polymer/
siRNA charge ratio did not affect the release of the siRNAs or
showed an opposite effect to that described for non-
thermoresponsive systems (Figure 4). In general, at 25 °C
(temperature of complex preparation), a very efficient
complexation was achieved, and the siRNAs were highly
shielded, similarly to what has been described for other cationic
polymers used as delivery systems.30 However, at 37 °C, the
siRNA protection decreased, as the polymers collapsed and
dissociated from the nucleic acids. This suggests that at this
temperature the increase in polymer concentration mostly
results in enhanced intra- and intermolecular hydrophobic
associations between the PNIPAAM blocks, contributing to the
formation of aggregated and compact structures. In other
words, the thermoresponsive properties of the copolymers are
dominant in the system, and an increase in charge ratio mostly
contributes to increase the associative behavior of PNIPAAM,
rather than contributing to protect the siRNA. In this context,
the polymer cloud point may also have guided the efficacy of
siRNA release, as previously discussed. However, the polymer
molecular weight and the number of charged PAMPTMA units
determine the number of polymer molecules needed in each
case to reach the desired complex charge ratio. Therefore, the
organization of the polymeric moieties around the siRNAs was
probably sufficiently diverse to lead to the observed differential
behavior regarding the nucleic acid release.
In spite of the much lower extent of internalization detected
by confocal microscopy, the n:m 48:20 polyplexes, at 10/1
(+/−) charge ratio, showed a relatively high level of GFP
knockdown (66%) as compared to that induced by n:m 48:6
complexes (85%), which should be attributed to their efficiency
in promoting siRNA release. Parallel silencing experiments
using lipofectamine RNAi max revealed that the n:m 48:20
copolymer is as efficient as this commercial reagent (65%) in
promoting gene knockdown. Interestingly, the polyplexes
formulated with the 48:20 copolymer, at the 10/1 (+/−)
charge ratio, were those presenting, at this charge ratio, the
largest hydrodynamic diameter at 25 °C (>580 nm) and were
the smallest (140 nm) at 37 °C. If, on the one hand, the large
hydrodynamic diameter at 25 °C might be associated with a
high siRNA load, the decay in size at 37 °C, on the other hand,
can reflect a collapse of the structure upon heating, promoting
the release of the entrapped nucleic acids, as described for other
drugs.10 Because of their small size, the siRNA molecules are
exposed after contraction of the copolymers at high temper-
atures, and their subsequent release by the temperature-induced
contraction of the copolymers favors the gene silencing
efficiency.
The general picture that emerges from this work is that the
silencing efficacy of the studied polyplexes depends on a
delicate interplay between repulsive electrostatic forces and
hydrophobic interactions, whose balance can be tuned by
changing the length of the PNIPAAM or PAMPTMA blocks,
which, in turn, defines polymer transition temperature and
charge density. The cloud point of the polymer showed, as
expected, high relevance for the biological activity achieved
upon interaction of the complexes with the cells. It should be
stressed that, in the present work, two promising siRNA
delivery systems were generated with the n:m 48:6 and n:m
48:20 copolymers and siRNA at the 10/1 (+/−) charge ratio,
which revealed high efficiency in silencing a reporter gene in a
fibrosarcoma cell line, even in the presence of serum. Under
these conditions, the formulation containing n:m 48:20
combines the best relationship between a relatively low-toxic
(65% of cell viability) and highly efficient gene silencing system,
with 68% of GFP knockdown and only 33% of unspecific gene
silencing. Although the size and nucleic acid protection levels of
the complexes may limit their application for intravenous
administration, the complexes under study can be useful for
local delivery into target cells.32
Overall, this study opens new trends for the engineering of
innovative therapeutic delivery systems from the combination
of materials whose properties can synergistically contribute to
enhance the efficacy of nucleic acid delivery. With a growing
understanding of polymeric drug delivery mechanisms, this
approach may be therefore of great relevance to generate new
and promising systems for gene therapies.
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